FIT - Fitbit, Inc.

NYSE - NYSE Delayed Price. Currency in USD
4.84
+0.22 (+4.76%)
At close: 4:04PM EDT

4.82 -0.02 (-0.41%)
After hours: 5:32PM EDT

Stock chart is not supported by your current browser
Previous Close4.62
Open4.60
Bid4.82 x 800
Ask4.92 x 3000
Day's Range4.60 - 5.05
52 Week Range4.46 - 7.79
Volume7,918,031
Avg. Volume5,636,581
Market Cap1.188B
Beta (3Y Monthly)1.67
PE Ratio (TTM)N/A
EPS (TTM)-1.50
Earnings DateOct 30, 2018 - Nov 5, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.39
Trade prices are not sourced from all markets
  • Winners and losers
    Yahoo Finance Video3 days ago

    Winners and losers

    Here are today's winners and losers in the stock market

  • Fitbit Charge 3 Unboxing
    CNET7 days ago

    Fitbit Charge 3 Unboxing

    CNET editors unbox the Fitbit Charge 3. This $150 fitness tracker has seven-day battery life and touts heart-rate sensing, water resistance and touchscreen improvements over its predecessor, the Fitbit Charge 2.

  • Fitbit Charge 3 is here: Here's what's new
    CNET10 days ago

    Fitbit Charge 3 is here: Here's what's new

    Should you get Fitbit's latest, and how is it different from the Fitbit Versa? A few key extras stand out.

  • Fitbit helps police nab woman's alleged killer, her stepfather
    CBS News Videos11 days ago

    Fitbit helps police nab woman's alleged killer, her stepfather

    A California woman's Fitbit led to her 90-year-old stepfather being charged with her murder. Anthony Aiello is accused of killing his 67-year-old stepdaughter, Karen Navarra, last month. Her Fitbit recorded a rapid rise in her heart rate before a sudden drop-off to nothing.

  • Apple Most Vulnerable to US Tariffs on Chinese Imports
    Market Realist7 hours ago

    Apple Most Vulnerable to US Tariffs on Chinese Imports

    Most analysts believe that the tariffs would not significantly impact semiconductor companies, but this cannot be said for Apple (AAPL), one of the biggest customers of the semiconductor industry. Apple has a huge dependency on both the United States and China.

  • Why Fitbit Stock Is Climbing Higher Today
    InvestorPlace3 days ago

    Why Fitbit Stock Is Climbing Higher Today

    Fitbit stock (NYSE:FIT) is surging more than 1% on Friday afternoon as the company’s latest product has been garnering positive reviews from tech journalists and fitness device aficionados.Source: Fitbit

  • Barrons.com3 days ago

    Where Fitbit’s Next Round of Growth Will Come From

    The smartwatch maker has been trying to wean itself from the consumer market and enmesh itself in the broader health-care industry.

  • Benzinga3 days ago

    Analyst Upgrades Fitbit Ahead Of Push Into MedTech Space

    Fitbit on Sept. 19 launched a new connected health platform called Fitbit Care, which combines health coaching and virtual care through a new app. The analysts said Fitbit's decision to work directly with employers, health plans and health systems creates a win-win scenario.

  • How Do Analysts View Fitbit Stock?
    Market Realist3 days ago

    How Do Analysts View Fitbit Stock?

    Fitbit stock (FIT) has declined significantly over the last few years. The stock touched an all-time high of $47.51 in August 2015 and has since fallen to $4.50. Fitbit stock declined 11% last month and is down 15.9% in October 2018. The stock has lost 21% in 2018. Fitbit was once the market leader in the global wearable market. However, it has since lost the position to Apple. A fall in product sales has impacted profitability as well.

  • Barrons.com3 days ago

    Tech Stocks Look Poised to Rally. Here’s What You Need to Know

    Tech stocks appear set for a good day on Friday, with shares of the FANGs and other hot tech stocks all up solidly premarket trading. Among the biggest winners were Square and Fitbit.

  • TheStreet.com3 days ago

    Fitbit Climbs Off Record Low Following Bullish Wedbush Note

    shares were up 6.22% in premarket trading on Friday, Oct. 12, lifting the med-tech company from its all-time low following a bullish note from analysts at Wedbush. Wedbush analyst Michael Pachter increased his rating to "outperform" from "neutral," where the firm has had the stock rated since November 2016. Google is a subsidiary of Alphabet Inc.

  • MarketWatch3 days ago

    Fitbit's stock jumps off record low after Wedbush turns bullish on MedTech opportunity

    Shares of Fitbit Inc. shot up 5.6% in premarket trade Friday, bouncing off a record close in the previous session, after Wedbush Securities turned bullish on the wearable device maker, citing optimism over the company's expansion into the healthcare-MedTech market. Analyst Michael Pachter raised his rating to outperform, after being at neutral since Nov. 2, 2016. "We've warmed up," Pachter wrote in a note to clients. "We think Fitbit has an excellent opportunity ahead with MedTech, particularly in collaboration with Google." He believes Fitbit will start reporting "meaningful contribution" from MedTech as early as 2019. "Additionally, shares have recently pulled back well below our $6.50 price target, providing an excellent opportunity to get involved in the Medtech vertical at a reasonable price," Pachter wrote. The stock has plunged 32% over the past three months, while the S&P 500 has lost 2.5%.

  • 4 of Chase Coleman's Tech Stocks Near 52-Week Lows
    GuruFocus.com4 days ago

    4 of Chase Coleman's Tech Stocks Near 52-Week Lows

    Several of tech guru’s holdings reach 52-week lows following Wednesday’s market selloff

  • See what the IHS Markit Score report has to say about Fitbit Inc.
    Markit4 days ago

    See what the IHS Markit Score report has to say about Fitbit Inc.

    Index (PMI) data, output in the Consumer Goods sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • How Far Could the US and China Go with Import Tariffs?
    Market Realist5 days ago

    How Far Could the US and China Go with Import Tariffs?

    The US–China (FXI) trade war is heating up and is starting to hurt the global supply chain. The United States is imposing tariffs on several Chinese imports in an effort to pressure China to abandon its unfair trade practices and to protect American intellectual property. China is retaliating with higher tariffs on US imports.

  • Why Fitbit Stock Lost 11% in September
    Motley Fool7 days ago

    Why Fitbit Stock Lost 11% in September

    Shares dipped as investors adjusted growth expectations heading into the key holiday shopping season.

  • Wearable Medical Device Boom Puts These 3 Stocks in Focus
    Zacks7 days ago

    Wearable Medical Device Boom Puts These 3 Stocks in Focus

    Americans depend on wearable medical devices for fitness tracking, blood pressure maintenance, self-glucose monitoring and more. Here, we discuss major companies that are raking in huge profits.

  • Fitbit (FIT) Latest Wearable Charge 3 Now Available Globally
    Zacks10 days ago

    Fitbit (FIT) Latest Wearable Charge 3 Now Available Globally

    Fitbit (FIT) has announced the global availability of its latest wearable device, Charge 3, which is priced at $149.95.

  • Fitbit data helps police arrest another murder suspect
    Engadget11 days ago

    Fitbit data helps police arrest another murder suspect

    Fitbit may have helped police solve the murder of one of its users, after investigators used heart rate data to determine the identity of the alleged killer. On September 8th, Anthony Aiello visited his 67-year-old stepdaughter Karen Navarra in San Jose. The data indicated that Navarra's heart rate "spiked significantly," then rapidly slowed and stopped -- all during the 15 minutes or so that Aiello, 90, was in her home, the New York Times reports.

  • Fitbit's Charge 3 goes on sale October 7th for $150
    Engadget11 days ago

    Fitbit's Charge 3 goes on sale October 7th for $150

    It's been over a month since Fitbit first announced the Charge 3, seemingly a major improvement over the two-year-old Charge 2 that it'll replace. If you've been wanting to replace an aging fitness tracker with Fitbit's latest, we now know the Charge 3 will arrive in just a few days -- October 7th, to be specific. In our initial testing, this made for a huge usability improvement over previous models, which used the accelerometer to register your actions, including jabbing at the screen.

  • Business Wire11 days ago

    Fitbit Announces Global Availability of Highly Anticipated Charge 3

    Fitbit (FIT), the leading global wearables brand, today announced the availability of Fitbit Charge 3™ at major retailers worldwide, online and at Fitbit.com for $149.95 (USD) beginning October 7.

  • Fitbit may have helped catch a killer, again
    TechCrunch12 days ago

    Fitbit may have helped catch a killer, again

    Fitbit data may have helped catch one of its customer's killers, and not for the first time.According to numerous media reports, a 90-year-old visited his stepdaughter at her home in San Jose, Ca.

  • InvestorPlace13 days ago

    Nio Stock May Not Be Able to Match the Performance of Tesla Stock

    For all of the disappointments Tesla (NASDAQ:TSLA) may have dished out, the current price of Tesla stock is still well above its IPO price. If the shares of Tesla’s Chinese rival Nio (NYSE:NIO) perform even half as well as TSLA stock did shortly after Tesla went public, NIO stock could still be a very rewarding trade. Indeed, NIO is in a much different situation than TSLA was in.

  • 3 Medical Devices Stocks to Buy
    InvestorPlace13 days ago

    3 Medical Devices Stocks to Buy

    When you think of medical devices stocks, you don’t think of cloud-connected watches. You want to invest in more prosaic companies, large and small, which offer discrete devices for specific conditions, with Food and Drug Administration (FDA) approvals and positive clinical trials. The long-term prognosis for medical devices is good, but many companies need to deal with short-term problems to get there, so look for strength – financial strength or strength within a winning niche – when you shop for investments.